Lobar or sublobar resection of peripheral stage I non-small cell lung cancer
We aim to highlight two recent clinical trials that have altered the approach of the management of stage I nonsmall cell lung cancer. The JCOG 0802 and CALGB 140503 trials demonstrated that sublobar resection is noninferior to lobectomy for overall and disease-free survival in patients with stage I...
Saved in:
| Published in: | Current opinion in pulmonary medicine Vol. 30; no. 4; pp. 352 - 358 |
|---|---|
| Main Authors: | , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
01-07-2024
|
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | We aim to highlight two recent clinical trials that have altered the approach of the management of stage I nonsmall cell lung cancer.
The JCOG 0802 and CALGB 140503 trials demonstrated that sublobar resection is noninferior to lobectomy for overall and disease-free survival in patients with stage I nonsmall cell lung cancer.
Since 1962, lobectomy has been deemed the gold standard treatment for operable lung cancer. However, two recent clinical trials have demonstrated that, for select patients, sublobar resection is oncologically noninferior; results, which are leading us into a new era for the surgical management of lung cancer. Notwithstanding the progress made by these studies and the opportunities that have been put forth, questions remain. This review aims at reviewing the results of both trials and to discuss future perspectives for the surgical treatment of lung cancer. |
|---|---|
| AbstractList | PURPOSE OF REVIEWWe aim to highlight two recent clinical trials that have altered the approach of the management of stage I nonsmall cell lung cancer.RECENT FINDINGSThe JCOG 0802 and CALGB 140503 trials demonstrated that sublobar resection is noninferior to lobectomy for overall and disease-free survival in patients with stage I nonsmall cell lung cancer.SUMMARYSince 1962, lobectomy has been deemed the gold standard treatment for operable lung cancer. However, two recent clinical trials have demonstrated that, for select patients, sublobar resection is oncologically noninferior; results, which are leading us into a new era for the surgical management of lung cancer. Notwithstanding the progress made by these studies and the opportunities that have been put forth, questions remain. This review aims at reviewing the results of both trials and to discuss future perspectives for the surgical treatment of lung cancer. We aim to highlight two recent clinical trials that have altered the approach of the management of stage I nonsmall cell lung cancer. The JCOG 0802 and CALGB 140503 trials demonstrated that sublobar resection is noninferior to lobectomy for overall and disease-free survival in patients with stage I nonsmall cell lung cancer. Since 1962, lobectomy has been deemed the gold standard treatment for operable lung cancer. However, two recent clinical trials have demonstrated that, for select patients, sublobar resection is oncologically noninferior; results, which are leading us into a new era for the surgical management of lung cancer. Notwithstanding the progress made by these studies and the opportunities that have been put forth, questions remain. This review aims at reviewing the results of both trials and to discuss future perspectives for the surgical treatment of lung cancer. |
| Author | Lima, Pedro Guimarães Rocha Glorion, Matthieu Liberman, Moishe |
| Author_xml | – sequence: 1 givenname: Pedro Guimarães Rocha surname: Lima fullname: Lima, Pedro Guimarães Rocha organization: Centre de Recherche de Centre Hospitalier de l'Université de Montréal (CRCHUM), Quebec, Canada – sequence: 2 givenname: Matthieu surname: Glorion fullname: Glorion, Matthieu organization: Centre de Recherche de Centre Hospitalier de l'Université de Montréal (CRCHUM), Quebec, Canada – sequence: 3 givenname: Moishe surname: Liberman fullname: Liberman, Moishe organization: Centre de Recherche de Centre Hospitalier de l'Université de Montréal (CRCHUM), Quebec, Canada |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38411206$$D View this record in MEDLINE/PubMed |
| BookMark | eNpdkLtOxDAQRS20iH3AHyDkkiaLn7FTohWPlYKggDpynPESlMTBTgr-niwLCDHFzC3uzFydJZp1vgOEzilZU5Kpq4fN05r8KUpSfoQWVHKapJmis0kTRRLJtJqjZYxvk4dllJ6gOdeCUkbSBcpzX5qAfcBxLJsvHSCCHWrfYe9wD6HuXyGYBsfB7ABv8ZQjia1pGmxhas3Y7bA1nYVwio6daSKcfc8Verm9ed7cJ_nj3XZznSeW6nRINFieVkxrAOJSUM4IRSzhUglJeMqIhNIQA04o66qKceHKzAldSkmFKBlfocvD3T749xHiULR13IcxHfgxFizjTHBNlJis4mC1wccYwBV9qFsTPgpKij3HYuJY_Oc4rV18fxjLFqrfpR9w_BN6-m7L |
| Cites_doi | 10.3390/cancers15112914 10.1016/j.jss.2012.11.052 10.1056/NEJMoa2202170 10.1056/NEJMoa2302983 10.1016/j.athoracsur.2015.12.073 10.1097/JTO.0000000000000664 10.1097/JTO.0b013e3182199c03 10.1016/0003-4975(95)00537-U 10.1016/j.jss.2015.08.045 10.1016/j.jtcvs.2023.07.008 10.1093/jjco/hyz122 10.1097/JTO.0b013e3181e2f607 10.1016/j.athoracsur.2023.11.021 10.1016/j.athoracsur.2019.07.037 10.1016/S1470-2045(15)70168-3 10.3322/caac.21654 10.3389/fsurg.2022.968199 10.1016/S0140-6736(21)02098-5 10.1016/S0022-5223(19)32943-5 10.1245/s10434-021-10213-9 10.1056/NEJMoa2212083 10.1016/j.athoracsur.2018.11.018 10.1093/ejcts/ezad018 10.1053/j.semtcvs.2019.07.007 10.1245/s10434-021-09835-w 10.1016/j.jtcvs.2020.09.146 10.1016/S0140-6736(21)02333-3 10.1097/PPO.0000000000000058 |
| ContentType | Journal Article |
| Copyright | Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved. |
| Copyright_xml | – notice: Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved. |
| DBID | NPM AAYXX CITATION 7X8 |
| DOI | 10.1097/MCP.0000000000001063 |
| DatabaseName | PubMed CrossRef MEDLINE - Academic |
| DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1531-6971 |
| EndPage | 358 |
| ExternalDocumentID | 10_1097_MCP_0000000000001063 38411206 |
| Genre | Journal Article |
| GroupedDBID | --- .-D .XZ .Z2 01Q 0R~ 4Q1 4Q2 4Q3 5GY 5VS 6PF 8L- AAAAV AAHPQ AAIQE AAJCS AAMTA AARTV AASCR AAUEB AAWTL AAYEP ABASU ABBUW ABDIG ABJNI ABVCZ ABXVJ ABZAD ACDDN ACEWG ACGFO ACGFS ACILI ACWDW ACWRI ACXJB ACXNZ ADGGA ADHPY AE6 AEBDS AENEX AFDTB AFEXH AFMFG AFSOK AHQNM AHVBC AINUH AJIOK AJNWD AJZMW ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AWKKM BQLVK C45 CS3 DIWNM DU5 E.X EBS EEVPB EX3 F5P FCALG FL- GNXGY GQDEL H0~ HLJTE HZ~ IKREB IN~ IPNFZ JK3 JK8 K8S KD2 L-C LEELO N9A NPM O9- OAG OAH ODA ODMTH OHYEH OLC OLG OLW OPUJH OVD OVDKG OVDNE OVKID OVOZU OWV OWW OWY OWZ OXXIT RIG RLZ S4R S4S TEORI TSPGW V2I VVN W3M WOQ WOW X3V X3W XYM YFH ZFV 53G AAYXX ADFPA ADNKB AE3 AEETU AJNYG BS7 CAG CITATION COF DUNZO EJD JF9 JG8 N~M OCUKA ORVUJ OUVQU OWU OWX P-K R58 T8P XO3 XXN ZZMQN 7X8 |
| ID | FETCH-LOGICAL-c186t-8ec36d288ee0f6e7fa470c035745036205eba0aef47cfdd234fb9f48b55144b23 |
| ISSN | 1070-5287 |
| IngestDate | Sat Oct 26 05:02:14 EDT 2024 Fri Nov 22 02:26:40 EST 2024 Sat Nov 02 12:27:10 EDT 2024 |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 4 |
| Language | English |
| License | Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c186t-8ec36d288ee0f6e7fa470c035745036205eba0aef47cfdd234fb9f48b55144b23 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
| PMID | 38411206 |
| PQID | 2932438074 |
| PQPubID | 23479 |
| PageCount | 7 |
| ParticipantIDs | proquest_miscellaneous_2932438074 crossref_primary_10_1097_MCP_0000000000001063 pubmed_primary_38411206 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-07-01 |
| PublicationDateYYYYMMDD | 2024-07-01 |
| PublicationDate_xml | – month: 07 year: 2024 text: 2024-07-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Current opinion in pulmonary medicine |
| PublicationTitleAlternate | Curr Opin Pulm Med |
| PublicationYear | 2024 |
| References | Forde (R26-20240821) 2022; 386 Ginsberg (R3-20240821) 1995; 60 Seder (R20-20240821) 2016; 101 Soo (R15-20240821) 2011; 6 Wang (R23-20240821) 2022; 9 Wakelee (R28-20240821) 2023; 389 Akamine (R17-20240821) 2023; 63 Towe (R4-20240821) 2024 Mimae (R19-20240821) 2021; 28 Khullar (R9-20240821) 2015; 10 Razi (R8-20240821) 2016; 200 Siegel (R12-20240821) 2021; 71 Chiang (R16-20240821) 2021; 28 Kawaguchi (R14-20240821) 2010; 5 Hedge (R25-20240821) 2020; 32 Shimkin (R2-20240821) 1962; 44 Suzuki (R11-20240821) 2022; 163 Chang (R29-20240821) 2015; 16 Handa (R22-20240821) 2019; 107 Saji (R6-20240821) 2022; 399 Felip (R27-20240821) 2021; 398 Lee (R21-20240821) 2023; 15 Altorki (R5-20240821) 2023; 388 Tsutani (R18-20240821) 2019; 49 Yendamuri (R7-20240821) 2013; 183 Tannenbaum (R13-20240821) 2014; 20 Robinson (R24-20240821) 2020; 109 Altorki (R10-20240821) 2024 |
| References_xml | – volume: 15 start-page: 2914 year: 2023 ident: R21-20240821 article-title: Sub-lobar resection: the new standard of care for early-stage lung cancer publication-title: Cancers (Basel) doi: 10.3390/cancers15112914 contributor: fullname: Lee – volume: 183 start-page: 27 year: 2013 ident: R7-20240821 article-title: Temporal trends in outcomes following sublobar and lobar resections for small (<2 cm) nonsmall cell lung cancers- a Surveillance Epidemiology End Results database analysis publication-title: J Surg Res doi: 10.1016/j.jss.2012.11.052 contributor: fullname: Yendamuri – volume: 386 start-page: 1973 year: 2022 ident: R26-20240821 article-title: Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa2202170 contributor: fullname: Forde – volume: 389 start-page: 491 year: 2023 ident: R28-20240821 article-title: Perioperative pembrolizumab for early-stage non–small-cell lung cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa2302983 contributor: fullname: Wakelee – volume: 101 start-page: 2077 year: 2016 ident: R20-20240821 article-title: Variation in pulmonary resection practices between the Society of Thoracic Surgeons and the European Society of Thoracic Surgeons General Thoracic Surgery Databases publication-title: Ann Thorac Surg doi: 10.1016/j.athoracsur.2015.12.073 contributor: fullname: Seder – volume: 10 start-page: 1625 year: 2015 ident: R9-20240821 article-title: Survival after sublobar resection versus lobectomy for clinical stage 1A lung cancer. An analysis from the National Cancer Data Base publication-title: J Thorac Oncol doi: 10.1097/JTO.0000000000000664 contributor: fullname: Khullar – volume: 6 start-page: 1030 year: 2011 ident: R15-20240821 article-title: Ethnic differences in survival outcome in patients with advanced stage nonsmall cell lung cancer: results of a meta-analysis of randomized controlled trials publication-title: J Thorac Oncol doi: 10.1097/JTO.0b013e3182199c03 contributor: fullname: Soo – volume: 60 start-page: 615 year: 1995 ident: R3-20240821 article-title: Randomized trial of lobectomy versus limited resection for T1 N0 nonsmall cell lung cancer publication-title: Ann Thorac Surg doi: 10.1016/0003-4975(95)00537-U contributor: fullname: Ginsberg – volume: 200 start-page: 683 year: 2016 ident: R8-20240821 article-title: Sublobar resection is equivalent to lobectomy for T1a nonsmall cell lung cancer in the elderly: a surveillance, epidemiology, and end results database analysis publication-title: J Surg Res doi: 10.1016/j.jss.2015.08.045 contributor: fullname: Razi – year: 2024 ident: R10-20240821 article-title: Lobectomy, segmentectomy, or wedge resection for peripheral clinical T1aN0 non–small cell lung cancer: a post hoc analysis of CALGB 140503 (Alliance) publication-title: J Thorac Cardiovasc Surg doi: 10.1016/j.jtcvs.2023.07.008 contributor: fullname: Altorki – volume: 49 start-page: 1134 year: 2019 ident: R18-20240821 article-title: Wedge resection versus segmentectomy in patients with stage I nonsmall cell lung cancer unfit for lobectomy publication-title: Jpn J Clin Oncol doi: 10.1093/jjco/hyz122 contributor: fullname: Tsutani – volume: 5 start-page: 1001 year: 2010 ident: R14-20240821 article-title: Japanese ethnicity compared with Caucasian ethnicity and never-smoking status are independent favorable prognostic factors for overall survival in nonsmall cell lung cancer: a collaborative epidemiologic study of the National Hospital Organization Study Group for Lung Cancer (NHSGLC) in Japan and a Southern California regional cancer registry databases publication-title: J Thorac Oncol doi: 10.1097/JTO.0b013e3181e2f607 contributor: fullname: Kawaguchi – year: 2024 ident: R4-20240821 article-title: The Society of Thoracic Surgeons General Thoracic Surgery Database: 2023 update on outcomes and research publication-title: Ann Thorac Surg doi: 10.1016/j.athoracsur.2023.11.021 contributor: fullname: Towe – volume: 109 start-page: 270 year: 2020 ident: R24-20240821 article-title: Prevalence of occult peribronchial N1 nodal metastasis in peripheral clinical N0 small (≤ 2 cm) non-small cell lung cancer publication-title: Ann Thorac Surg doi: 10.1016/j.athoracsur.2019.07.037 contributor: fullname: Robinson – volume: 16 start-page: 630 year: 2015 ident: R29-20240821 article-title: Stereotactic ablative radiotherapy versus lobectomy for operable stage I nonsmall-cell lung cancer: a pooled analysis of two randomised trials publication-title: Lancet Oncol doi: 10.1016/S1470-2045(15)70168-3 contributor: fullname: Chang – volume: 71 start-page: 7 year: 2021 ident: R12-20240821 article-title: Cancer Statistics, 2021 publication-title: CA Cancer J Clin doi: 10.3322/caac.21654 contributor: fullname: Siegel – volume: 9 start-page: 968199 year: 2022 ident: R23-20240821 article-title: Application of three-dimensional (3D) reconstruction in the treatment of video-assisted thoracoscopic complex segmentectomy of the lower lung lobe: a retrospective study publication-title: Front Surg doi: 10.3389/fsurg.2022.968199 contributor: fullname: Wang – volume: 398 start-page: 1344 year: 2021 ident: R27-20240821 article-title: Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA nonsmall-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial publication-title: Lancet doi: 10.1016/S0140-6736(21)02098-5 contributor: fullname: Felip – volume: 44 start-page: 503 year: 1962 ident: R2-20240821 article-title: Pneumonectomy and lobectomy in bronchogenic carcinoma: a comparison of end results of the Overholt and Ochsner clinics publication-title: J Thorac Cardiovasc Surg doi: 10.1016/S0022-5223(19)32943-5 contributor: fullname: Shimkin – volume: 28 start-page: 8398 year: 2021 ident: R16-20240821 article-title: Thoracoscopic wedge resection versus segmentectomy for cT1N0 lung adenocarcinoma publication-title: Ann Surg Oncol doi: 10.1245/s10434-021-10213-9 contributor: fullname: Chiang – volume: 388 start-page: 489 year: 2023 ident: R5-20240821 article-title: Lobar or sublobar resection for peripheral stage IA non–small-cell lung cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa2212083 contributor: fullname: Altorki – volume: 107 start-page: 1032 year: 2019 ident: R22-20240821 article-title: Surgical Outcomes of complex versus simple segmentectomy for stage 1 nonsmall cell lung cancer publication-title: Ann Thorac Surg doi: 10.1016/j.athoracsur.2018.11.018 contributor: fullname: Handa – volume: 63 start-page: ezad018 year: 2023 ident: R17-20240821 article-title: Feasibility and effectiveness of segmentectomy versus wedge resection for clinical stage I nonsmall cell lung cancer publication-title: Eur J Cardiothorac Surg doi: 10.1093/ejcts/ezad018 contributor: fullname: Akamine – volume: 32 start-page: 162 year: 2020 ident: R25-20240821 article-title: Endosonographic mediastinal lymph node staging in positron emission tomography and computed tomography node-negative non–small-cell lung cancer in high-risk patients publication-title: Semin Thorac Cardiovasc Surg doi: 10.1053/j.semtcvs.2019.07.007 contributor: fullname: Hedge – volume: 28 start-page: 7219 year: 2021 ident: R19-20240821 article-title: Survival of octogenarians with early-stage nonsmall cell lung cancer is comparable between wedge resection and lobectomy/segmentectomy: JACS1303 publication-title: Ann Surg Oncol doi: 10.1245/s10434-021-09835-w contributor: fullname: Mimae – volume: 163 start-page: 289.e2 year: 2022 ident: R11-20240821 article-title: A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer publication-title: J Thorac Cardiovasc Surg doi: 10.1016/j.jtcvs.2020.09.146 contributor: fullname: Suzuki – volume: 399 start-page: 1607 year: 2022 ident: R6-20240821 article-title: Segmentectomy versus lobectomy in small-sized peripheral nonsmall-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, noninferiority trial publication-title: Lancet doi: 10.1016/S0140-6736(21)02333-3 contributor: fullname: Saji – volume: 20 start-page: 237 year: 2014 ident: R13-20240821 article-title: Survival disparities in nonsmall cell lung cancer by race, ethnicity, and socioeconomic status publication-title: Cancer J doi: 10.1097/PPO.0000000000000058 contributor: fullname: Tannenbaum |
| SSID | ssj0012911 |
| Score | 2.431513 |
| SecondaryResourceType | review_article |
| Snippet | We aim to highlight two recent clinical trials that have altered the approach of the management of stage I nonsmall cell lung cancer.
The JCOG 0802 and CALGB... PURPOSE OF REVIEWWe aim to highlight two recent clinical trials that have altered the approach of the management of stage I nonsmall cell lung cancer.RECENT... |
| SourceID | proquest crossref pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 352 |
| Title | Lobar or sublobar resection of peripheral stage I non-small cell lung cancer |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/38411206 https://www.proquest.com/docview/2932438074 |
| Volume | 30 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3da9swEBdrC2MvZd9L1w0N9hbMbEm27MeuTdaC243Nhb4Zy5ZZII2LXf__u7MkO-026B6WB2MUImPdL_eh-92JkI-CSQBCkHgRDyBACUPpJVyFXlIVlQaHxC8VFgqf_pAXV_HJQiwmStA09l8lDWMga6yc_Qdpj5PCANyDzOEKUofrg-Sewh-0RZZ516v1cI8FRqVzDLGx8dBJAMtEkK9zNt80G6-7xhQ17uLP1z2W4SIY2m3P1TVywgIry4-86dfwWki7u5-hT1fXhWH_Vm0DMMSOFkNKnutu_r0pf47G4AsyAC2DH48eX-l-mkSh2TDfNcjd396iYGKks4KFcWo18KLEHLbi9K7Nx6y2NxUGJcpNT1trj7lp7f6bqjcthM-Pv5kWlPYDES6fTJtL5198zZeXaZpni6tsh-wxUEqgE_eOlifZ5zHnxEDvu-LKRH7608x3nZe_RCSDZ5I9Jfs2pKBHBgvPyCO9eU4en1uRvCDpAAnatNRBgo6QoE1NJ0jQARL0jI6QoAgJipCgBhIvyeVykR2fevYQDa8M4ujWi3XJo4rFsdZ-HWlZF0L6pc9DKUL0XvxQq8IvdC1kWVcV46JWSS1iha60UIy_IrvwUP2GUAbKHhydxOeKibAE-8SV5nFUJKwIIlnMiOdWJ78xvVJyx3GA1czvr-aMfHBLmINSwxcqNrrpuxx8UDYchSBm5LVZ23FGHguIEfzo4AG_fkueTHg8JLu3ba_fkZ2u6t9b6f8CIghxCg |
| link.rule.ids | 315,782,786,27933,27934 |
| linkProvider | Ovid |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Lobar+or+sublobar+resection+of+peripheral+stage+I+non-small+cell+lung+cancer&rft.jtitle=Current+opinion+in+pulmonary+medicine&rft.au=Lima%2C+Pedro+Guimar%C3%A3es+Rocha&rft.au=Glorion%2C+Matthieu&rft.au=Liberman%2C+Moishe&rft.date=2024-07-01&rft.eissn=1531-6971&rft.volume=30&rft.issue=4&rft.spage=352&rft.epage=358&rft_id=info:doi/10.1097%2FMCP.0000000000001063&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1070-5287&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1070-5287&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1070-5287&client=summon |